--- schema_version: "secwatch.filing_event.v1" accession: "0001023459-25-000035" form_type: "8-K" ticker: "SLP" cik: "0001023459" company_name: "Simulations Plus, Inc." filed_at: "2025-06-02T23:59:59+00:00" generated_at: "2026-05-20T02:19:18.817301+00:00" event_type: "other_material" sentiment: "neutral" materiality_score: 0.65 calibrated_materiality_score: 0.65 confidence: "high" source: SEC EDGAR --- # Simulations Plus appoints new CRO, restructures workforce; cuts 23 jobs (~10%), expects $4.3M annual savings ## Summary - John DiBella appointed Chief Revenue Officer; Daniel Szot departs at end of fiscal Q3 for other opportunities. - Other leadership changes: Will Frederick named EVP/CFO, Josh Fohey becomes COO; several divisional role adjustments. - Workforce reduction of ~23 employees (10% of full-time staff) to improve operational efficiency. - Estimated $0.7M severance charges in FY2025; expects $4.3M annualized operating expense reduction. - No changes to employment agreements or compensation for appointees; no familial relationships disclosed. ## SEC filing metadata - accession: 0001023459-25-000035 - form_type: 8-K - ticker: SLP - cik: 0001023459 - company_name: Simulations Plus, Inc. - filed_at: 2025-06-02T23:59:59+00:00 - event_type: other_material - sentiment: neutral - materiality_score: 0.65 - calibrated_materiality_score: 0.65 - confidence: high - sec_items: 5.02, 2.05, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1023459/000102345925000035/0001023459-25-000035-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1023459/000102345925000035/slp-20250530.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001023459-25-000035 - JSON: https://secwatch.observer/filing/0001023459-25-000035.json - Plain text: https://secwatch.observer/filing/0001023459-25-000035.txt ## Key facts - Executive change Erik Guffrey changed role as Co-Chief Product and Technology Officer at Simulations Plus, Inc.. - Action: assumes new role - Role: Co-Chief Product and Technology Officer source text: Erik Guffrey , currently Chief Technology Officer, Adaptive Learning & Insights and Medical Communications Products, assumes the new role of Co-Chief Product and Technology Officer. evidence_url: https://www.sec.gov/Archives/edgar/data/1023459/000102345925000035/0001023459-25-000035-index.htm - Executive change Dr. Jonathan Chauvin changed role as Co-Chief Product and Technology Officer at Simulations Plus, Inc.. - Action: assumes new role - Role: Co-Chief Product and Technology Officer source text: Dr. Jonathan Chauvin , currently Business Unit Co-President, Clinical Pharmacology & Pharmacometric Solutions, assumes the new role of Co-Chief Product and Technology Officer. evidence_url: https://www.sec.gov/Archives/edgar/data/1023459/000102345925000035/0001023459-25-000035-index.htm - Executive change Josh Fohey changed role as Chief Operating Officer at Simulations Plus, Inc.. - Action: assumes new role - Role: Chief Operating Officer source text: Josh Fohey , currently Senior Vice President, Operations, assumes the new role of Chief Operating Officer. evidence_url: https://www.sec.gov/Archives/edgar/data/1023459/000102345925000035/0001023459-25-000035-index.htm - Executive change John DiBella was appointed as Chief Revenue Officer at Simulations Plus, Inc.. - Action: appointed - Role: Chief Revenue Officer source text: On May 30, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Simulations Plus, Inc. (the “Company”) appointed John DiBella as Chief Revenue Officer of the Company, effective immediately. evidence_url: https://www.sec.gov/Archives/edgar/data/1023459/000102345925000035/0001023459-25-000035-index.htm - Executive change Steven Chang changed role as Global Head of Strategic Alliances at Simulations Plus, Inc.. - Action: assumes new role - Role: Global Head of Strategic Alliances source text: Steven Chang , currently Business Unit President, Quantitative Systems Pharmacology Solutions, assumes the new role of Global Head of Strategic Alliances. evidence_url: https://www.sec.gov/Archives/edgar/data/1023459/000102345925000035/0001023459-25-000035-index.htm - Executive change Jill Fiedler-Kelly changed role as Interim President, Services Solutions at Simulations Plus, Inc.. - Action: assumes new role - Role: Interim President, Services Solutions source text: Jill Fiedler-Kelly , currently Business Unit Co-President, Clinical Pharmacology & Pharmacometric Solutions, assumes the new role of Interim President, Services Solutions. evidence_url: https://www.sec.gov/Archives/edgar/data/1023459/000102345925000035/0001023459-25-000035-index.htm - Executive change Will Frederick changed role as Executive Vice President and Chief Financial Officer at Simulations Plus, Inc.. - Action: assumes new role - Role: Executive Vice President and Chief Financial Officer source text: Will Frederick , currently Chief Financial Officer and Chief Operating Officer, assumes the new role of Executive Vice President and Chief Financial Officer. evidence_url: https://www.sec.gov/Archives/edgar/data/1023459/000102345925000035/0001023459-25-000035-index.htm - Executive change Daniel Szot departed as Chief Revenue Officer at Simulations Plus, Inc.. - Action: separated - Role: Chief Revenue Officer source text: On the Effective Date, the Company and Daniel Szot, the Company’s Chief Revenue Officer, mutually agreed to Mr. Szot’s separation from the Company, to take effect at the end of the third fiscal quarter which allows for smooth transition as Mr. Szot seeks to pursue other opportunities. evidence_url: https://www.sec.gov/Archives/edgar/data/1023459/000102345925000035/0001023459-25-000035-index.htm - Restructurings & Charges Simulations Plus, Inc. announced a restructuring with charges of approximately $0.7 million (approximately 23 employees). - Type: restructuring - Charge: approximately $0.7 million - Headcount: approximately 23 employees source text: The reduction in workforce will decrease overall headcount by approximately 23 employees, which represents approximately 10% of full-time employees as of the Effective Date. The Company estimates that it will incur approximately $0.7 million in charges in connection with the restructuring, consisting of severance payments, employee benefits, and related costs evidence_url: https://www.sec.gov/Archives/edgar/data/1023459/000102345925000035/0001023459-25-000035-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.